Clinical Research Pharmacies and Clinical Trials - Permits and Ownership

Summary

The bill establishes a new clinical research pharmacy permit that the State Board of Pharmacy must issue. It permits health‑care providers to hold an ownership interest in such pharmacies only if a licensed pharmacist is on‑site at all times and referral or remuneration rules are followed. It also removes corporate investigational trials from the legal definition of practicing medicine, clarifying licensing requirements.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Hearings

• Health — Bill Hearing
  Health · Mar 5, 2026

History

1. Apr 13, 2026Third Reading Passed
2. Apr 13, 2026Second Reading Passed with Amendments
3. Apr 13, 2026Referred Rules
4. Apr 13, 2026Favorable with Amendments {
5. Apr 11, 2026Favorable with Amendments Report by Health
6. Feb 13, 2026Hearing 3/05 at 1:00 p.m.
7. Feb 13, 2026First Reading Health

Sponsors

• Solomon · sponsor
• Bagnall
• Cullison
• Guzzone
• Hill
• Hutchinson
• Kaufman
• Kipke
• Lopez
• Martinez
• Reilly
• Rosenberg
• Ross
• S. Johnson
• Taveras
• White Holland
• Woorman

Bill text

Opens the legislature’s own copy.

Similar bills in other states

Loading the map of where bills like this one were filed.

Topics

Share